Introduction to Susceptibility Weighted Imaging

Susceptibility Weighted Imaging in MRI: Basic Concepts and Clinical Applications

Volumn , Issue , 2011, Pages 1-16

  Haacke, E Mark ^a,b,c,d,e   Reichenbach, Jürgen R ^f  

^a WAYNE STATE UNIVERSITY   (United States)

^b MRI Institute for Biomedical Research   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d LOMA LINDA UNIVERSITY   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Filtered phase images, direct susceptibility information not a direct map of actual susceptibility; Susceptibility weighted imaging (SWI) in realm of magnetic resonance imaging (MRI) techniques; SWI, signal loss and phase information anatomical and physiological information of vessels and tissues

Indexed keywords

EID: 84886151953     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470905203.ch1     Document Type: Editorial

References (43)

1. Ogawa S, Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn. Reson. Med. 1990;16:9-18.
2. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 1990;14:68-78.
3. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA 1990;87:9868-9872.
4. Lai S, Hopkins AL, Haacke EM, Li D,WassermanBA, Buckley P, Friedman L, Meltzer H, Hedera P, Friedland R. Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5 T: preliminary results. Magn. Reson. Med. 1993;30:387-392.
5. Haacke EM, Hopkins A, Lai S, Buckley P, Friedman L, Meltzer H, Hedera P, Friedland R, Klein S, Thompson L, Detterman D, Tkach J, Lewin JS. 2D and 3D high resolution gradient echo functional imaging of the brain: venous contributions to signal in motor cortex studies. NMR Biomed. 1994;7 (1-2):54-62. Erratum in NMR Biomed. 1994;7:374.
6. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994;32:749-763.
7. Haacke EM, Lai S, Yablonskiy DA, Lin W. In vivo validation of theBOLDmechanism: a reviewof signal changes in gradient echo functional MRI in the presence of flow. Int. J. Imaging Syst. Technol. 1995;6:153-163.
8. Moser E, Teichtmeister C, Diemling M. Reproducibility and postprocessing of gradient-echo functional MRI to improve localization of brain activity in the human visual cortex. Magn. Reson. Imaging 1996;14:567-579.
9. Lai S, Reichenbach JR, Haacke EM. Commutator filter: a novel technique for the identification of structures producing significant susceptibility inhomogeneities and its application to functional MRI. Magn. Reson. Med. 1996;36:781-787.
10. Barth M, Diemling M, Moser E. Modulation of signal changes in gradient-recalled echo functional MRI with increasing echo time correlate with model calculations. Magn. Reson. Imaging 1997;15:745-752.
11. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J. Magn. Reson. Imaging 1997;7:266-279.
12. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ. Functional cerebral imaging by susceptibility-contrast NMR. Magn. Reson. Med. 1990;14:538-546.
13. Reichenbach JR,Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272-277.
14. Haacke EM, Lai S, Reichenbach JR, Kuppusamy K, Hoogenraad FGC, Takeichi H, Lin W. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum. Brain Mapp. 1997;5:341-346.
15. Hoogenraad FG, Reichenbach JR, Haacke EM, Lai S, Kuppusamy K, Sprenger M. In vivo measurement of changes in venous blood-oxygenation with high resolution functional MRI at 0.95 tesla by measuring changes in susceptibility and velocity. Magn. Reson. Med. 1998;39:97-107.
16. Wang Y, Yu Y, Li D, Bae KT, Brown JJ, Lin W, Haacke EM. Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J. Magn. Reson. Imaging 2000;12:661-670.
17. Reichenbach JR, Essig M, Haacke EM, Lee BC, Przetak C, Kaiser WA, Schad LR. High-resolution venography of the brain using magnetic resonance imaging. MAGMA 1998;6:62-69.
18. Barth M, Reichenbach JR, Venkatesan R, Moser E, Haacke EM. High-resolution, multiple gradient-echo functional MRI at 1.5 T. Magn. Reson. Imaging 1999;17:321-329.
19. Hoogenraad FG, Hofman MB, Pouwels PJ, Reichenbach JR, Rombouts SA, Haacke EM. Submillimeter fMRI at 1.5 Tesla: correlation of high resolution with low resolution measurements. J. Magn. Reson. Imaging 1999;9:475-482.
20. Hoogenraad FG, Pouwels PJ, Hofman MB, Reichenbach JR, Sprenger M, Haacke EM. Quantitative differentiation between BOLD models in fMRI. Magn. Reson. Med. 2001;45:233-246.
21. Lai S, Glover GH, Haacke EM. Spatial selectivity of BOLD contrasts: effects in and around draining veins. In: MoonenC TW, Bandettini PA, editors. Functional MRI, Springer, Berlin, 1999, pp.221-231.
22. Lee BC, Vo KD, Kido DK, Mukherjee P, Reichenbach J, LinW, Yoon MS, Haacke M. MR highresolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am. J. Neuroradiol. 1999;20:1239-1242.
23. Reichenbach JR, Jonetz-Mentzel L, Fitzek C, Haacke EM, Kido DK, Lee BC, KaiserWA. Highresolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology 2001;43:364-369.
24. Essig M, Reichenbach JR, Schad LR, Schoenberg SO, Debus J, Kaiser WA. High-resolution MR venography of cerebral arteriovenous malformations. Magn. Reson. Imaging 1999;17: 1417-1425.
25. Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F. MR venography of multiple sclerosis. AJNR Am. J. Neuroradiol. 2000;21:1039-1042.
26. Haacke EM, Herigault G, Kido D, Tong K, Obenaus A, Yu Y, Reichenbach JR. Observing tumor vascularity noninvasively using magnetic resonance imaging. Image Anal. Stereol. 2002;21:107-113.
27. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453-467.
28. Baudendistel KT, Reichenbach JR, Metzner R, Schroeder J, Schad LR. Comparison of functional MR-venography and EPI-BOLD fMRI at 1.5 T. Magn. Reson. Imaging 1998;16:989-991.
29. Schad LR. Improved target volume characterization in stereotactic treatment planning of brain lesions by using high-resolution BOLD MR-venography. NMR Biomed. 2001;14:478-483.
30. Lin W, Mukherjee P, An H, Yu Y, Wang Y, Vo K, Lee B, Kido D, Haacke EM. Improving highresolution MR BOLD venographic imaging using a T1 reducing contrast agent. J. Magn. Reson. Imaging 1999;10:118-123.
31. Reichenbach JR, Barth M, Haacke EM, Klarhöfer M, KaiserWA, Moser E. High-resolution MR venography at 3.0 Tesla. J. Comput. Assist. Tomogr. 2000;24:949-957.
32. Dashner RA, Kangarlu A, Clark DL, Chaudhury AR, Chakeres DW. Limits of 8-Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvasculature. J. Magn. Reson. Imaging 2004;19:303-307.
33. Abduljalil AM, Schmalbrock P, NovakV, ChakeresDW. Enhanced gray and white matter contrast of phase susceptibility weighted images in ultra-high-field magnetic resonance imaging. J. Magn. Reson. Imaging 2003;18:284-290.
34. Rauscher A, Barth M, Reichenbach JR, Stollberger R, Moser E. Automated unwrapping of MR phase images applied to BOLD MR-venography at 3 Tesla. J. Magn. Reson. Imaging 2003;18:175-180.
35. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility weighted MR phase imaging of the human brain. AJNR Am. J. Neuroradiol. 2005;26:736-742.
36. Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008;60:1155-1168.
37. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res. Bull. 1981;7:519-579.
38. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004;52:612-618.
39. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005;23:1-25.
40. Ohnishi T, Nakano S, Yano T, Hoshi H, Jinnouchi S, Nagamachi S, Flores L, 2nd, Watanabe K, Yokogami K, Ohta H. Susceptibility weighted MR for evaluation of vasodilatory capacity with acetazolamide challenge. AJNR Am. J. Neuroradiol. 1996;17:631-637.
41. Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, Gollapalli L, Ciulla C, Kim I, Petersen F, Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J. Magn. Reson. Imaging 2007;26:256-264.
42. Marques JP, Bowtell R. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn. Reson. 2005;25B:65-78.
43. Salomir R, de Senneville BD, Moonen CTW. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of susceptibility. Concepts Magn. Reson. 2003;19B:26-34.